3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Cholangiocarcinoma
6
Colorectal Neoplasms
5
Klatskin Tumor
4
Carcinoma, Hepatocellular
4
Fibrosis
3
Neoplasm Metastasis
2
Liver Neoplasms
2
Liver Diseases
2
Reperfusion Injury
1
Rejection, Psychology
1
Recurrence
1
Neoplasms
1
Hypertension, Portal
1
Gastrointestinal Stromal Tumors
1
Colorectal Liver Metastases
1
Cholangitis, Sclerosing
1
Bile Duct Neoplasms
1
Interventions
Radiotherapy
10
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
8
Cyclosporine
7
Cyclophosphamide
7
Busulfan
7
Whole-Body Irradiation
6
Melphalan
6
Radiofrequency Ablation
5
Mycophenolic Acid
5
Filgrastim
5
Antilymphocyte Serum
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Methotrexate
4
Etoposide
4
Drug Therapy
4
Cisplatin
4
fludarabine
3
Radiosurgery
3
Injections
3
Hepatectomy
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
lenvatinib
2
Vinblastine
2
Videotape Recording
2
Thiotepa
2
Standard of Care
2
Sorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recurrence
×
Liver Transplantation
×
Clear all
NCT04499833
2022-06-06
HepatoPredict
Centro Hospitalar de Lisboa Central
Phase NA
Recruiting
40 enrolled